Your browser doesn't support javascript.
loading
Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma.
Foote, M C; McGrath, M; Guminski, A; Hughes, B G M; Meakin, J; Thomson, D; Zarate, D; Simpson, F; Porceddu, S V.
Affiliation
  • Foote MC; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane; Diamantina Institute, University of Queensland, Brisbane, Australia. Electronic address: matthew.foote@health.qld.gov.au.
  • McGrath M; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane.
  • Guminski A; Department Medical Oncology, Royal North Shore Hospital, Sydney.
  • Hughes BGM; Department Medical Oncology, Royal Brisbane and Womens Hospital, Brisbane.
  • Meakin J; Research Unit, Cancer Services, Princess Alexandra Hospital, Brisbane.
  • Thomson D; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane.
  • Zarate D; Queensland Cancer Control Analysis Team, Queensland Health, Brisbane.
  • Simpson F; Diamantina Institute, University of Queensland, Brisbane, Australia.
  • Porceddu SV; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane; Diamantina Institute, University of Queensland, Brisbane, Australia.
Ann Oncol ; 25(10): 2047-2052, 2014 Oct.
Article in En | MEDLINE | ID: mdl-25091317

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Antibodies, Monoclonal Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Antibodies, Monoclonal Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: United kingdom